» Articles » PMID: 38685022

Relationship Between Vaginal and Oral Microbiome in Patients of Human Papillomavirus (HPV) Infection and Cervical Cancer

Overview
Journal J Transl Med
Publisher Biomed Central
Date 2024 Apr 29
PMID 38685022
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The aim of this study was to assess the microbial variations and biomarkers in the vaginal and oral environments of patients with human papillomavirus (HPV) and cervical cancer (CC) and to develop novel prediction models.

Materials And Methods: This study included 164 samples collected from both the vaginal tract and oral subgingival plaque of 82 women. The participants were divided into four distinct groups based on their vaginal and oral samples: the control group (Z/KZ, n = 22), abortion group (AB/KAB, n = 17), HPV-infected group (HP/KHP, n = 21), and cervical cancer group (CC/KCC, n = 22). Microbiota analysis was conducted using full-length 16S rDNA gene sequencing with the PacBio platform.

Results: The vaginal bacterial community in the Z and AB groups exhibited a relatively simple structure predominantly dominated by Lactobacillus. However, CC group shows high abundances of anaerobic bacteria and alpha diversity. Biomarkers such as Bacteroides, Mycoplasma, Bacillus, Dialister, Porphyromonas, Anaerococcus, and Prevotella were identified as indicators of CC. Correlations were established between elevated blood C-reactive protein (CRP) levels and local/systemic inflammation, pregnancy, childbirth, and abortion, which contribute to unevenness in the vaginal microenvironment. The altered microbial diversity in the CC group was confirmed by amino acid metabolism. Oral microbial diversity exhibited an inverse pattern to that of the vaginal microbiome, indicating a unique relationship. The microbial diversity of the KCC group was significantly lower than that of the KZ group, indicating a link between oral health and cancer development. Several microbes, including Fusobacterium, Campylobacter, Capnocytophaga, Veillonella, Streptococcus, Lachnoanaerobaculum, Propionibacterium, Prevotella, Lactobacillus, and Neisseria, were identified as CC biomarkers. Moreover, periodontal pathogens were associated with blood CRP levels and oral hygiene conditions. Elevated oral microbial amino acid metabolism in the CC group was closely linked to the presence of pathogens. Positive correlations indicated a synergistic relationship between vaginal and oral bacteria.

Conclusion: HPV infection and CC impact both the vaginal and oral microenvironments, affecting systemic metabolism and the synergy between bacteria. This suggests that the use of oral flora markers is a potential screening tool for the diagnosis of CC.

Citing Articles

HPV Infection and Oral Microbiota: Interactions and Future Implications.

Xia Q, Pierson S Int J Mol Sci. 2025; 26(4).

PMID: 40003891 PMC: 11855562. DOI: 10.3390/ijms26041424.


Associations of the gut, cervical, and vaginal microbiota with cervical cancer: a systematic review and meta-analysis.

Wen Q, Wang S, Min Y, Liu X, Fang J, Lang J BMC Womens Health. 2025; 25(1):65.

PMID: 39955550 PMC: 11829412. DOI: 10.1186/s12905-025-03599-1.


Oral microbiota: the overlooked catalyst in cancer initiation and progression.

Wang X, He X, Zhong B Front Cell Dev Biol. 2025; 12:1479720.

PMID: 39872848 PMC: 11769975. DOI: 10.3389/fcell.2024.1479720.


The correlation between vaginal pathogens and high-risk human papilloma virus infection: a meta-analysis of case-control studies.

Yang J, Long X, Li S, Zhou M, Hu L Front Oncol. 2024; 14:1423118.

PMID: 39640283 PMC: 11618108. DOI: 10.3389/fonc.2024.1423118.


Altered microbial diversity and composition of multiple mucosal organs in cervical cancer patients.

Peng L, Ai C, Dou Z, Li K, Jiang M, Wu X BMC Cancer. 2024; 24(1):1154.

PMID: 39289617 PMC: 11409810. DOI: 10.1186/s12885-024-12915-1.


References
1.
Desvarieux M, Demmer R, Rundek T, Boden-Albala B, Jacobs Jr D, Sacco R . Periodontal microbiota and carotid intima-media thickness: the Oral Infections and Vascular Disease Epidemiology Study (INVEST). Circulation. 2005; 111(5):576-82. PMC: 2812915. DOI: 10.1161/01.CIR.0000154582.37101.15. View

2.
Radaic A, Ganther S, Kamarajan P, Grandis J, Yom S, Kapila Y . Paradigm shift in the pathogenesis and treatment of oral cancer and other cancers focused on the oralome and antimicrobial-based therapeutics. Periodontol 2000. 2021; 87(1):76-93. PMC: 8415008. DOI: 10.1111/prd.12388. View

3.
Chattopadhyay I, Lu W, Manikam R, Malarvili M, Ambati R, Gundamaraju R . Can metagenomics unravel the impact of oral bacteriome in human diseases?. Biotechnol Genet Eng Rev. 2022; 39(1):85-117. DOI: 10.1080/02648725.2022.2102877. View

4.
Shi J, Yang Y, Xie H, Wang X, Wu J, Long J . Association of oral microbiota with lung cancer risk in a low-income population in the Southeastern USA. Cancer Causes Control. 2021; 32(12):1423-1432. PMC: 8541916. DOI: 10.1007/s10552-021-01490-6. View

5.
Persson R, Hitti J, Verhelst R, Vaneechoutte M, Persson R, Hirschi R . The vaginal microflora in relation to gingivitis. BMC Infect Dis. 2009; 9:6. PMC: 2637877. DOI: 10.1186/1471-2334-9-6. View